Last Price
0.68
Today's Change
+0.20 (41.66%)
Day's Change
0.655 - 0.76
Trading Volume
39,987,280
Overview
Market Cap
380 Million
Shares Outstanding
559 Million
Avg Volume
1,561,955
Avg Price (50 Days)
0.44
Avg Price (200 Days)
0.42
PE Ratio
-17.00
EPS
-0.04
Earnings Announcement
21-Jul-2025
Previous Close
0.48
Open
0.75
Day's Range
0.655 - 0.76
Year Range
0.3 - 0.76
Trading Volume
39,987,280
Price Change Highlight
1 Day Change
41.67%
5 Day Change
58.14%
1 Month Change
60.00%
3 Month Change
51.11%
6 Month Change
74.36%
Ytd Change
82.80%
1 Year Change
112.50%
3 Year Change
122.95%
5 Year Change
122.95%
10 Year Change
122.95%
Max Change
122.95%
News and Blogs
No result.
Company Profile
Sector: Healthcare - Healthcare
Industry: Biotechnology
Description:
Dimerix Limited, a biopharmaceutical company, develops and commercializes pharmaceutical products for unmet medical needs. It develops DMX-200 that is in two Phase 3 clinical trials for COVID respiratory complications; DMX-200, a Phase 3 clinical trial for focal segmental glomerulosclerosis disease; DMX-200 for diabetic kidney disease; and DMX-700 for chronic obstructive pulmonary disease. The company is headquartered in Fitzroy, Australia.
Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment
Latest Videos
.png)
Apps
Top Articles
#
Stock
Score
Daily Stocks
Stock
Last
Change
Volume
Ride The Bull Short The Bear
CS Tan
4.9 / 5.0
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
